2435. Clinical Outcomes With Ceftolozane–Tazobactam in Patients With Multidrug-Resistant (MDR) Pseudomonas aeruginosa Bloodstream Infections: A Multi-Center Study

por King, Madeline, Elabor, Abdulrahman, Molnar, Esther, Gallagher, Jason
Publicado 2018

2382. Ceftolozane/Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients: A Multi-Center Study

por Elabor, Abdulrahman, Molnar, Esther, King, Madeline, Gallagher, Jason
Publicado 2018

Ceftolozane-tazobactam for the Treatment of Multi Drug-resistant Pseudomonas aeruginosa (MDRPA) Infections

por Molnar, Esther, Heil, Emily, Claeys, Kimberly, Hiles, Jon, Gallagher, Jason
Publicado 2017

2657. Clinical Prediction Tool for Multidrug-Resistant Organisms Among Deceased Donors at the Time of Donor Evaluation

por Anesi, Judith A, Anesi, Judith A, Blumberg, Emily, Han, Jennifer, Lee, Dong Heun, Clauss, Heather, Climaco, Antonette, Hasz, Richard, Molnar, Esther, Alimenti, Darcy, West, Sharon, Bilker, Warren, Tolomeo, Pam C, Lautenbach, Ebbing
Publicado 2019

1385. Impact of Deceased Organ Donor Injection Drug Use on Donor Culture Positivity

por Moore, Krista, Lautenbach, Ebbing, Blumberg, Emily, Han, Jennifer, Lee, Dong Heun, Clauss, Heather, Hasz, Richard, Bilker, Warren, Climaco, Antonette, Molnar, Esther, Alimenti, Darcy, West, Sharon, Tolomeo, Pam C, Anesi, Judith A, Anesi, Judith A
Publicado 2021

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study

por Gallagher, Jason C, Satlin, Michael J, Elabor, Abdulrahman, Saraiya, Nidhi, McCreary, Erin K, Molnar, Esther, El-Beyrouty, Claudine, Jones, Bruce M, Dixit, Deepali, Heil, Emily L, Claeys, Kimberly C, Hiles, Jon, Vyas, Nikunj M, Bland, Christopher M, Suh, Jin, Biason, Kenneth, McCoy, Dorothy, King, Madeline A, Richards, Lynette, Harrington, Nicole, Guo, Yi, Chaudhry, Saira, Lu, Xiaoning, Yu, Daohai
Publicado 2018